{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:17Z","timestamp":1787070917099,"version":"build-2736575974"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>SARS-CoV-2 infection presentation in children is usually milder than in adults but can be severe and fatal as well. Data on the pediatric population regarding severity and clinical presentation are still limited, and there is a need to have a better understanding of clinical features, severity, and laboratory parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objective:<\/jats:title>\n                    <jats:p>To document clinical and laboratory characteristics and outcomes of children with SARS-CoV-2 in a low-middle-income country and to evaluate clinicodemographic factors and biochemical markers associated with severity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A hospital-based cross-sectional study was conducted among 112 COVID-19-positive children at a designated Level-3 center in North India. Clinical characteristics, laboratory parameters, and severity of COVID-19 cases as well as factors associated with the severity of the disease, were analyzed by descriptive statistics and a Chi-square test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The adolescent age group (age 12-18 years) was affected most (64.3%). Male patients accounted for 56.3% of total cases. Fever was the most common symptom (41.1%) followed by cough. Presenting complaints were highest from the respiratory system (32.1%) followed by the gastrointestinal (8.9%) and the neurological system (7.1%). Majority of patients had mild disease (87%) while 13% had the moderate-severe disease. Spo\n                      <jats:sub>2<\/jats:sub>\n                      &lt; 95% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.00001), neutrophilia (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.000001), lymphopenia (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.000001), elevated values of C-reactive protein (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001), Interleukin-6 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002), D- dimer (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.00014) and respiratory symptoms as presenting complaints (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.000001) were found to be significantly associated with severity of disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The male and adolescent age group was affected most. Presenting complaints were highest from the respiratory system. Unusual presentation may have gastrointestinal or neurological presentation. Most children with COVID-19 had mild disease. Moderate to severe disease was not uncommon. Factors including neutrophilia, lymphopenia, elevated lab values of C-reactive protein, D-dimer, and interleukin-6 had a significant association with the severity of the disease. These biomarkers can help predict the severity of the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1734_23","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T22:00:28Z","timestamp":1719352828000},"page":"2653-2662","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A cross-sectional study on clinical characteristics and severity of children with COVID-19 admitted to a teaching institute in North India"],"prefix":"10.4103","volume":"13","author":[{"given":"Deepty","family":"Nauriyal","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Subharti Medical, College, Meerut, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabh","family":"Dubey","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Subharti Medical, College, Meerut, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulak","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Subharti Medical, College, Meerut, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Maharishi Markandeshwar University and Hospital, Solan, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Punj","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Subharti Medical, College, Meerut, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaynat","family":"Nasser","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Subharti Medical College, Meerut, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12519-020-00343-7","article-title":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: Experts'consensus statement","volume":"16","author":"Shen","year":"2020","journal-title":"World J Pediatr"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.2020.4344","article-title":"Coronavirus disease 2019 (COVID-19) in Italy","volume":"323","author":"Livingston","year":"2020","journal-title":"JAMA"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jinf.2020.02.024","article-title":"Corona Virus Disease, 2019, a growing threat to children?","volume":"80","author":"Yang","year":"2020","journal-title":"J Infect"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3345\/cep.2020.00535","article-title":"Epidemiology and clinical features of coronavirus disease 2019 in children","volume":"63","author":"Choi","year":"2020","journal-title":"Clin Exp Pediatr"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12098-021-03822-5","article-title":"Clinical profile of COVID-19 illness in children\u2014Experience from a tertiary care hospital","volume":"89","author":"Singh","year":"2022","journal-title":"Indian J Pediatr"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/ppul.24734","article-title":"Insight into COVID-2019 for pediatricians","volume":"55","author":"Li","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMc2005073","article-title":"SARS-CoV-2 infection in children","volume":"382","author":"Lu","year":"2020","journal-title":"N Engl J Med"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N Engl J Med"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"e0283220","DOI":"10.1371\/journal.pone.0283220","article-title":"Burden and severity of deranged electrolytes and Kidney function in children seen in a tertiary hospital in Kano, northern Nigeria","volume":"18","author":"Obiagwu","year":"2023","journal-title":"PLos one"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.2020006479","article-title":"Anemia in the pediatric patient","volume":"140","author":"Gallagher","year":"2022","journal-title":"Blood"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1038\/s41598-021-89553-1","article-title":"A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States","volume":"11","author":"Parcha","year":"2021","journal-title":"Sci Rep"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/jcsr.jcsr_66_22","article-title":"Predictors of severity in COVID-19","volume":"12","author":"Pereka","year":"2023","journal-title":"J Clin Sci Res"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"e0246312","DOI":"10.1371\/journal.pone.0246312","article-title":"Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?","volume":"16","author":"Schneider","year":"2021","journal-title":"PLoS One"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fmed.2020.00526","article-title":"Pulmonary and extra-pulmonary clinical manifestations of COVID-19","volume":"7","author":"Johnson","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.clinre.2020.06.015","article-title":"Self-limited gastrointestinal bleeding in COVID-19","volume":"44","author":"Barrett","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/joim.13209","article-title":"Prevalence and 6-month recovery of olfactory dysfunction: A multicentre study of 1363 COVID-19 patients","volume":"290","author":"Lechien","year":"2021","journal-title":"J Intern Med"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.htct.2021.12.001","article-title":"Hematological changes in SARS-COV-2 positive patients","volume":"44","author":"Urbano","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"869","DOI":"10.12669\/pjms.37.3.3848","article-title":"Is leukopenia and lymphopenia a characteristic feature of COVID-19 in children?","volume":"37","author":"Bari","year":"2021","journal-title":"Pak J Med Sci"},{"key":"R28-20240828","first-page":"8028725","article-title":"The role of innate leukocytes during influenza virus infection","author":"Lamichhane","year":"2019","journal-title":"J Immunol Res 2019"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1385\/IR:24:2:163","article-title":"C-reactive protein, inflammation, and innate immunity","volume":"24","author":"Mortensen","year":"2001","journal-title":"Immunol Res"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaci.2020.05.003","article-title":"Longitudinal, hematologic and immunologic variations associated with the progression of COVID-19 patients in China [J","volume":"146","author":"Chen","year":"2020","journal-title":"Allergy Clin Immunol"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chom.2013.01.005","article-title":"Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps","volume":"13","author":"Jenne","year":"2013","journal-title":"Cell Host Microbe"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/JLB.4COVCRA0820-481RRR","article-title":"Neutrophils mediate Th17 promotion in COVID-19 patients","volume":"109","author":"Parackova","year":"2021","journal-title":"J Leukoc Biol"},{"key":"R33-20240828","first-page":"43","article-title":"Spectrum of hematological changes in COVID-19","volume":"12","author":"Gajendra","year":"2022","journal-title":"Am J Blood Res"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bjh.16794","article-title":"Autoimmune haemolytic anaemia associated with COVID-19 infection","volume":"190","author":"Lazarian","year":"2020","journal-title":"Br J Haematol"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10238-020-00679-4","article-title":"Anemia in patients with Covid-19: Pathogenesis and clinical significance","volume":"21","author":"Bergamaschi","year":"2021","journal-title":"Clin Exp Med"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"638097","DOI":"10.3389\/fmed.2021.638097","article-title":"Clinical significance of plasma D-dimer in COVID-19 mortality","volume":"8","author":"Li","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"1076029620962853","DOI":"10.1177\/1076029620962853","article-title":"COVID-19 and hypercoagulability: A review","volume":"26","author":"Kichloo","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.14960","article-title":"Fibrinolysis and COVID-19: A plasmin paradox","volume":"18","author":"Medcalf","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"fmaa045","DOI":"10.1093\/tropej\/fmaa045","article-title":"Radiological findings of COVID-19 in children: A systematic review and meta-analysis","volume":"67","author":"Kumar","year":"2021","journal-title":"J Trop Pediatr"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/qjmed\/hcab138","article-title":"Corticosteroids for treating mild COVID-19: Opening the floodgates of therapeutic misadventure","volume":"114","author":"Ray","year":"2021","journal-title":"QJM"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/17425255.2015.992779","article-title":"Tocilizumab for treating rheumatoid arthritis: An evaluation of pharmacokinetics\/pharmacodynamics and clinical efficacy","volume":"11","author":"Song","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"173926","DOI":"10.1016\/j.ejphar.2021.173926","article-title":"Remdesivir for treatment of COVID-19;an updated systematic review and meta-analysis","volume":"897","author":"Rezagholizadeh","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"808187","DOI":"10.3389\/fped.2021.808187","article-title":"COVID-19 in pediatrics: Demographic, clinical, laboratory, and radiological characteristics of infected patients with SARS-CoV-2","volume":"9","author":"Najafinejad","year":"2021","journal-title":"Front Pediatr"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12931-022-02222-3","article-title":"Impact of upper and lower respiratory symptoms on COVID-19 outcomes: A multicenter retrospective cohort study","volume":"23","author":"Nakagawara","year":"2022","journal-title":"Respir Res"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/ALN.0000000000003578","article-title":"\u201cSilent\u201d presentation of hypoxemia and cardiorespiratory compensation in COVID-19","volume":"134","author":"Bickler","year":"2021","journal-title":"Anesthesiology"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/23744235.2020.1784457","article-title":"Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection","volume":"52","author":"Gidari","year":"2020","journal-title":"Infect Dis (Lond)"},{"key":"R53-20240828","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/emp2.12230","article-title":"The safety of home discharge for low-risk emergency department patients presenting with coronavirus-like symptoms during the COVID-19 pandemic: A retrospective cohort study","volume":"1","author":"Berdahl","year":"2020","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/sji.12967","article-title":"Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms","volume":"93","author":"Jafarzadeh","year":"2021","journal-title":"Scand J immunol"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: Retrospective analysis","volume":"326","author":"Wong","year":"2003","journal-title":"BMJ"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chom.2013.01.005","article-title":"Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps","volume":"13","author":"Jenne","year":"2013","journal-title":"Cell Host Microbe"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"R60-20240828","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1172\/JCI138554","article-title":"Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent","volume":"130","author":"Mazzoni","year":"2020","journal-title":"J Clin Invest"},{"key":"R61-20240828","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"R62-20240828","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"key":"R63-20240828","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/cid\/ciaa462","article-title":"Downregulated gene expression spectrum and immune responses changed during the disease progression in patients with COVID-19","volume":"71","author":"Ouyang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R64-20240828","doi-asserted-by":"crossref","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa","year":"2021","journal-title":"Front Immunol"},{"key":"R65-20240828","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.7754\/Clin.Lab.2022.220741","article-title":"Interleukin-6 (IL-6) as a predictor of clinical outcomes in patients with COVID-19","volume":"69","author":"Mahmood","year":"2023","journal-title":"Clin Lab"},{"key":"R66-20240828","doi-asserted-by":"crossref","first-page":"e36037","DOI":"10.1097\/MD.0000000000036037","article-title":"Interleukin-6 and the determinants of severe COVID-19: A retrospective cohort study","volume":"102","author":"Hafez","year":"2023","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1734_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:51Z","timestamp":1787067531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1734_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1734_23","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"2023-10-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}